Q4 2025 earnings call recap: 2026 revenue guidance, margin gains, CPT reimbursement catalyst, and consumables outlook—read now.

OGM VIA customers represent a meaningful software revenue stream and a natural on-ramp to broader Bionano Genomics, Inc. adoption at these customer sites. The IONIQ system continues to expand, ...

PROCEPT BioRobotics trades at 2.9x forward EV/2026E revenue, a deep discount to peers, despite 27-33% guided revenue growth. Learn why PRCT stock is a buy.

Cursor accesses the Kimi K2.5 model through Fireworks AI, which provides hosted inference and reinforcement learning ...

Attributed Q4 revenue declines to supply constraints from a manufacturing partner for silicon wafers, creating a backlog of ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2025. "2025 demonstrated the momentum we built as a business,” commented ...

Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.

Many people dream of solid jobs with good pay, yet years of school (and mountains of debt) often stand in the way. Careers with short training paths change that picture entirely. You can enter fields ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2025. "2025 demonstrated the ...

Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2025 Earnings Call Transcript March 23, 2026 Bionano Genomics, Inc. reports earnings ...

Earlier today, Hyperfine Inc. released financial results for the quarter ending December 31, 2025. Before we begin, I'd like ...

DMedical shares (ASX: 4DX) had a huge day in the markets today, soaring to an all-time high after announcing that the world's ...